Cipla Suspends Effort To Buy Majority Of South Africa's Cipla Medpro
This article was originally published in PharmAsia News
Executive Summary
Cipla has suspended its effort to buy a majority stake in the South Africa drug maker Cipla Medpro that shares its name, citing issues concerning its valuation.
You may also be interested in...
ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
FDA Sets New Restrictions For Authorized N95 Decontamination Systems
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Biden Signs COVID-19 Relief EO To Expand And Accelerate Testing, Fill PPE Shortages
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports